Business Wire

Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. For $19.75 per Share in Cash

The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly ...
The Caledonian-Record

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), ...

Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Platinum will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple trials and evaluation programs.
Business Wire

Obagi Medical Products Introduces Hydrate

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin-health systems, announces the launch of Obagi Hydrate. This new ...
GEN

Valeant Portfolio Shows More Skin with $360M Obagi Deal

Valeant Pharmaceuticals International said today it plans to acquire Obagi Medical Products in an approximately $360 million deal that would strengthen the buyer’s portfolio of dermatology treatments ...
TMCnet

Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

Through this real-world evaluation collaboration, Alpha will conduct a structured, multi-site evaluation of Obagi ® saypha ® MagIQ™ across its network of practices. The program will leverage Alpha’s ...